Treatment of Osteopenia in Children with Insulin-dependent Diabetes Mellitus: the Effect of 1 Alpha-hydroxyvitamin D3

Overview

Journal Eur J Pediatr

Specialty Pediatrics

Date 1996 Jan 1

PMID 8750803

Citations 2

Authors

I Voskaki

C Kassiou

H Athanasopoulou

E Sarafidou

C S Bartsocas

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Twelve children (8 boys and 4 girls) with insulin-dependent diabetes mellitus (IDDM), aged 9-15 years, received 1 alpha-hydroxyvitamin D3 (1 alpha-OHD3) in a dose of 0.05 microgram/kg per day for 1 year. Duration of disease varied between 2.8 and 9 years. Bone density was determined in the distal third of forearm using single photon absorptiometry, and was expressed as standard scores (+/- SD) with respect to sex- and age-matched controls. Bone density measurements and ultrasound studies of the kidneys were performed at 0, 6 and 12 months. Serum calcium, ionized calcium, phosphorus, magnesium, creatinine, alkaline phosphatase, glycosylated haemoglobin in morning blood samples and urinary Ca, P, Mg, and hydroxyproline were regularly determined. One patient was excluded from the study because of hypercalciuria and one because of lack of compliance. Bone density increased significantly after 6 and 12 months of 1 alpha-OHD3 administration (P = 0.015, P < 0.001 respectively). None of the biochemical parameters changed significantly.

Conclusion: Osteopenia is not uncommon in children and adolescents with IDDM. In 10 children with IDDM and osteopenia the administration of 1 alpha-OHD3 for 1 year corrected bone loss.

Citing Articles

Systematic review: associations of calcium intake, vitamin D intake, and physical activity with skeletal outcomes in people with Type 1 diabetes mellitus.

Cristina Gil-Diaz M, Raynor J, OBrien K, Schwartz G, Weber D Acta Diabetol. 2019; 56(10):1091-1102.

PMID: 30989378 PMC: 6751023. DOI: 10.1007/s00592-019-01334-5.

Effect of physical exercise on bone density and remodeling in egyptian type 1 diabetic osteopenic adolescents.

Elhabashy S, Said O, Agaiby M, Abdelrazek A, Abdelhamid S Diabetol Metab Syndr. 2011; 3:25.

PMID: 21961506 PMC: 3206406. DOI: 10.1186/1758-5996-3-25.

References

Chesney R, Shore R . The noninvasive determination of bone mineral content by photon absorptiometry. Am J Dis Child. 1982; 136(7):578-80. DOI: 10.1001/archpedi.1982.03970430010002. View

Rodland O, Markestad T, Aksnes L, AARSKOG D . Plasma concentrations of vitamin D metabolites during puberty of diabetic children. Diabetologia. 1985; 28(9):663-6. DOI: 10.1007/BF00291972. View

Spencer E, Khalil M, Tobiassen O . Experimental diabetes in the rat causes an insulin-reversible decrease in renal 25-hydroxyvitamin D3-1 alpha-hydroxylase activity. Endocrinology. 1980; 107(1):300-5. DOI: 10.1210/endo-107-1-300. View

Hui S, Epstein S, JOHNSTON Jr C . A prospective study of bone mass in patients with type I diabetes. J Clin Endocrinol Metab. 1985; 60(1):74-80. DOI: 10.1210/jcem-60-1-74. View

Wiske P, Wentworth S, NORTON Jr J, Epstein S, JOHNSTON Jr C . Evaluation of bone mass and growth in young diabetics. Metabolism. 1982; 31(8):848-54. DOI: 10.1016/0026-0495(82)90086-5. View

Shore R, Chesney R, Mazess R, Rose P, Bargman G . Osteopenia in juvenile diabetes. Calcif Tissue Int. 1981; 33(5):455-7. DOI: 10.1007/BF02409473. View

Rosenbloom A, Lezotte D, Weber F, Gudat J, Heller D, Weber M . Diminution of bone mass in childhood diabetes. Diabetes. 1977; 26(11):1052-5. DOI: 10.2337/diab.26.11.1052. View

Hough F . Alterations of bone and mineral metabolism in diabetes mellitus. Part II. Clinical studies in 206 patients with type I diabetes mellitus. S Afr Med J. 1987; 72(2):120-6. View

Bouillon R . Diabetic bone disease. Calcif Tissue Int. 1991; 49(3):155-60. DOI: 10.1007/BF02556109. View

10.

Verhaeghe J, Van Herck E, Visser W, Suiker A, Thomasset M, Einhorn T . Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes. 1990; 39(4):477-82. DOI: 10.2337/diab.39.4.477. View

11.

McNair P, Madsbad S, Christiansen C, Faber O, TRANSBOL I, Binder C . Osteopenia in insulin treated diabetes mellitus. Its relation to age at onset, sex and duration of disease. Diabetologia. 1978; 15(2):87-90. DOI: 10.1007/BF00422250. View

12.

Rico H, Hernandez E, Cabranes J, Gomez-Castresana F . Suggestion of a deficient osteoblastic function in diabetes mellitus: the possible cause of osteopenia in diabetics. Calcif Tissue Int. 1989; 45(2):71-3. DOI: 10.1007/BF02561404. View

13.

Rosenbloom A . Skeletal and joint manifestations of childhood diabetes. Pediatr Clin North Am. 1984; 31(3):569-89. DOI: 10.1016/s0031-3955(16)34607-7. View

14.

Frazer T, White N, Hough S, Santiago J, McGee B, Bryce G . Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J Clin Endocrinol Metab. 1981; 53(6):1154-9. DOI: 10.1210/jcem-53-6-1154. View

15.

Saggese G, Bertelloni S, Baroncelli G, Federico G, Calisti L, Fusaro C . Bone demineralization and impaired mineral metabolism in insulin-dependent diabetes mellitus. A possible role of magnesium deficiency. Helv Paediatr Acta. 1989; 43(5-6):405-14. View

16.

Hough S, Fausto A, Sonn Y, Dong Jo O, Birge S, Avioli L . Vitamin D metabolism in the chronic streptozotocin-induced diabetic rat. Endocrinology. 1983; 113(2):790-6. DOI: 10.1210/endo-113-2-790. View

17.

Leon M, LARRODERA L, Lledo G, Hawkins F . Study of bone loss in diabetes mellitus type 1. Diabetes Res Clin Pract. 1989; 6(3):237-42. DOI: 10.1016/0168-8227(89)90035-1. View